Head-to-head · WeighScore
Tonik Wellness vs WeightCare
By GLP-1 ScorecardUpdated
Score comparison
Tonik Wellness has the higher recorded score — 69/100 to 52.2/100.
Tonik Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tonik lists monthly, quarterly and annual GLP-1 plans. Its medication subscription policy sets a three-month minimum.
Before you choose
Before comparing the headline prices, the Tonik Wellness review and the WeightCare review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Tonik Wellness vs yourEra and Valhalla Vitality vs WeightCare compare each of them with another graded program, and the list of alternatives to Tonik Wellness ranks the programs closest to Tonik Wellness on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the SkinnyRx review covers one graded close to these two, at 60.5/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Tonik Wellness | WeightCare |
|---|---|---|
| WeighScore | 69/100 | 52.2/100 |
| Grade | C | C |
| Site position | #150 | #498 |
| Semaglutide | $225/mo (advertised monthly plan, minimum commitment applies) | $249/mo on a 3-month plan ($139/mo on a 12-month plan) |
| Tirzepatide | $349/mo (advertised monthly plan, minimum commitment applies) | $299/mo on a 3-month starter plan ($216/mo on a 12-month plan, any dose) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Shows quarterly and annual billing amounts for both advertised medications.
- Describes lab review with a provider.
- Names Strive and Olympia as partner pharmacies.
What to consider
- Monthly access language needs reconciling with the three-month subscription minimum.
- The plan cards leave lab charges and the selected dispensing location unconfirmed.
FDAWarning letter issued to Weightless Medical LLC dba WeightCare in February 2026. See the FDA warning-letter database.
Strengths
- PCAB-accredited pharmacy partners — strongest pharmacy quality signal
- Quality testing: potency and sterility per USP 797 standards
- 85,000+ members since 2022 — established patient base
- Multiple program tiers for semaglutide
- Health coaching, dietitians, fitness trainers included
What to consider
- No LegitScript certification on the site itself
- State availability not explicitly listed
- Compounded only — no brand-name options
- The lowest rates ($139 semaglutide, $216 tirzepatide) require a 12-month plan; 3-month plans are $249 and $299
- FDA issued Weightless Medical LLC dba WeightCare a warning letter in February 2026; the letter is public in FDA's warning-letter database
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.